
Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device.
Benzinga reached out to DexCom for comments and is yet to hear from them.

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device.
Benzinga reached out to DexCom for comments and is yet to hear from them.